The biotechnology sector in the country is reeling from a funds crunch, affecting its business growth despite the industry attaining an average growth in the range of 15-20 per cent in the past......
Dr Reddy's Laboratories has offered Euro 450-million (about Rs 2,500 crore) for acquiring German generic drugs major Betapharm Arzneimittel GmbH.The deal, if it goes through, will be the biggest......
Dr Reddy's Laboratories is planning a big-ticket acquisition in Europe to strengthen its generics portfolio in the world's second largest drug market. To this end, the company is exploring suitable......
Dr Reddy's Laboratories, two years after floating its American depository shares issue, is still maintaining $30 million in bank deposits to meet its future investment needs. Of the $125.4 million......
Benchmark share indices scaled record highs for the fourth straight session, amid a rallly in global stocks, after the European Central Bank announced higher-than-expected monetary stimulus......